Repopulating activity of ex vivo-expanded murine hematopoietic stem cells resides in the CD48-c-Kit+Sca-1+ lineage marker- cell population

Stem Cells

Volumn 26, Issue 3, 2008, Pages 646-655

  Noda, Shinichi ^a,b   Horiguchi, Kana ^a   Ichikawa, Hitoshi ^c   Miyoshi, Hiroyuki ^a  

^a RIKEN BIORESOURCE CENTER   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cell surface markers; Ex vivo expansion; Hematopoietic stem cells; Long term repopulation; Microarray; Mouse

Indexed keywords

ATAXIN 1; CD48 ANTIGEN; FIBROBLAST GROWTH FACTOR 1; SOMATOMEDIN B; STEM CELL FACTOR; THROMBOPOIETIN; ATAXIN-1; BIOLOGICAL MARKER; CYTOKINE; LEUKOCYTE ANTIGEN; NERVE PROTEIN; NUCLEAR PROTEIN; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL EXPANSION; CELL LINEAGE; CULTURE MEDIUM; HEMATOPOIETIC STEM CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL CLONE; CELL CYCLE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION PROFILING; KINETICS; METABOLISM;

MURINAE;

ANIMALS; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL CYCLE; CELL LINEAGE; CELL PROLIFERATION; CLONE CELLS; CYTOKINES; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; KINETICS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 43049133310     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0623     Document Type: Article

References (47)

1. Kondo M, Wagers AJ, Manz MG et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 2003;21:759-806.
2. Shizuru JA, Negrin RS, Weissman IL. Hematopoietic stem and progenitor cells: Clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 2005;56:509-538.
3. Devine SM, Lazarus HM, Emerson SG. Clinical application of hematopoietic progenitor cell expansion: Current status and future prospects. Bone Marrow Transplant 2003;31:241-252.
4. Sauvageau G, Iscove NN, Humphries RK. In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 2004;23:7223-7232.
5. Sorrentino BP. Clinical strategies for expansion of haematopoietic stem cells. Nat Rev Immunol 2004;4:878-888.
6. Sadlon TJ, Lewis ID, D'Andrea RJ. BMP4: Its role in development of the hematopoietic system and potential as a hematopoietic growth factor. STEM CELLS 2004;22:457-474.
7. Willert K, Brown JD, Danenberg E et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003;423:448-452.
8. de Haan G, Weersing E, Dontje B et al. In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev Cell 2003;4:241-251.
9. Krosl J, Austin P, Beslu N et al. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 2003;9:1428-1432.
10. Knobel KM, McNally MA, Berson AE et al. Long-term reconstitution of mice after ex vivo expansion of bone marrow cells: Differential activity of cultured bone marrow and enriched stem cell populations. Exp Hematol 1994;22:1227-1235.
11. Peters SO, Kittler EL, Ramshaw HS et al. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 1995;23:461-469.
12. Traycoff CM, Cornetta K, Yoder MC et al. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp Hematol 1996;24:299-306.
13. Bhatia M, Bonnet D, Kapp U et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997;186:619-624.
14. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 2000;96:4185-4193.
15. Ema H, Takano H, Sudo K et al. In vitro self-renewal division of hematopoietic stem cells. J Exp Med 2000;192:1281-1288.
16. Majka M, Janowska-Wieczorek A, Ratajczak J et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001;97:3075-3085.
17. Madlambayan GJ, Rogers I, Kirouac DC et al. Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol 2005;33:1229-1239.
18. Osawa M, Hanada K, Hamada H et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245.
19. Takano H, Ema H, Sudo K et al. Asymmetric division and lineage commitment at the level of hematopoietic stem cells: Inference from differentiation in daughter cell and granddaughter cell pairs. J Exp Med 2004;199:295-302.
20. Bunting KD, Galipeau J, Topham D et al. Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture. Ann N Y Acad Sci 1999;872:125-140; discussion 140-141.
21. Dorrell C, Gan OI, Pereira DS et al. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function. Blood 2000;95:102-110.
22. Al-Shahrour F, Diaz-Uriarte R, Dopazo J. FatiGO: A web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 2004;20:578-580.
23. Zhang CC, Lodish HF. Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion. Blood 2005;105:4314-4320.
24. Zeng H, Yucel R, Kosan C et al. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J 2004;23:4116-4125.
25. Hock H, Hamblen MJ, Rooke HM et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 2004;431:1002-1007.
26. Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2006;6:11-23.
27. Yoshikawa K. Cell cycle regulators in neural stem cells and postmitotic neurons. Neurosci Res 2000;37:1-14.
28. Galiana E, Vernier P, Dupont E et al. Identification of a neural-specific cDNA, NPDC-1, able to down-regulate cell proliferation and to suppress transformation. Proc Natl Acad Sci U S A 1995;92:1560-1564.
29. Sansal I, Dupont E, Toru D et al. NPDC-1, a regulator of neural cell proliferation and differentiation, interacts with E2F-1, reduces its binding to DNA and modulates its transcriptional activity. Oncogene 2000;19:5000-5009.
30. Kim I, Yilmaz OH, Morrison SJ. CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells. Blood 2005;106:903-905.
31. Balazs AB, Fabian AJ, Esmon CT et al. Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood 2006;107:2317-2321.
32. Matsuzaki Y, Kinjo K, Mulligan RC et al. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity 2004;20:87-93.
33. Camargo FD, Chambers SM, Drew E et al. Hematopoietic stem cells do not engraft with absolute efficiencies. Blood 2006;107:501-507.
34. Morita Y, Ema H, Yamazaki S et al. Non-side-population hematopoietic stem cells in mouse bone marrow. Blood 2006;108:2850-2856.
35. Sitnicka E, Lin N, Priestley GV et al. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 1996;87:4998-5005.
36. Ku H, Yonemura Y, Kaushansky K et al. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 1996;87:4544-4551.
37. Zhang CC, Lodish HF. Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood 2004;103:2513-2521.
38. Yeoh JS, van Os R, Weersing E et al. Fibroblast growth factor-1 and-2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures. STEM CELLS 2006;24:1564-1572.
39. Kiel MJ, Yilmaz OH, Iwashita T et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005;121:1109-1121.
40. Yilmaz OH, Kiel MJ, Morrison SJ. SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity. Blood 2006;107:924-930.
41. Kim I, He S, Yilmaz OH et al. Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors. Blood 2006;108:737-744.
42. Venezia TA, Merchant AA, Ramos CA et al. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol 2004;2:e301.
43. Nygren JM, Bryder D, Jacobsen SE. Prolonged cell cycle transit is a defining and developmentally conserved hemopoietic stem cell property. J Immunol 2006;177:201-208.
44. Dykstra B, Ramunas J, Kent D et al. High-resolution video monitoring of hematopoietic stem cells cultured in single-cell arrays identifies new features of self-renewal. Proc Natl Acad Sci U S A 2006;103:8185-8190.
45. Srour EF, Tong X, Sung KW et al. Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0. Blood 2005;105:3109-3116.
46. Cheng T, Rodrigues N, Shen H et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000;287:1804-1808.
47. Yu H, Yuan Y, Shen H et al. Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners. Blood 2006;107:1200-1206.